CN Patent

CN104404046A — 用于治疗补体-相关失调的适体治疗

Assigned to Archemix Corp · Expires 2015-03-11 · 11y expired

What this patent protects

本发明提供了核酸治疗及在补体-相关失调的治疗中使用这些核酸治疗的方法。

USPTO Abstract

本发明提供了核酸治疗及在补体-相关失调的治疗中使用这些核酸治疗的方法。

Drugs covered by this patent

avacincaptad-pegol-sodium (AVACINCAPTAD PEGOL SODIUM)

Patent Metadata

Patent number: CN104404046A
Jurisdiction: CN
Classification: —
Expires: 2015-03-11
Drug substance claim: No
Drug product claim: No
Assignee: Archemix Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.